home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

1,060 rows where has_known_aptamer = 0, in_cev_map = 0 and tier = "Tier 1" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

surface_class 5

  • B_cargo 642
  • A_surface 209
  • unknown 111
  • A2_pm_peripheral 51
  • A_assoc 47

has_structure 2

  • 1 959
  • 0 101

has_cryoEM 2

  • 0 663
  • 1 397

tier 1

  • Tier 1 · 1,060 ✖

in_cev_map 1

  • - · 1,060 ✖

has_known_aptamer 1

  • - · 1,060 ✖

has_activation_state_pdb_pair 1

  • 0 1,060
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
Q14654 KCNJ11 ATP-sensitive inward rectifier potassium channel 11 Tier 1 0.81 1 A_surface 9 83.81 1 0     0 0   0 type 2 diabetes mellitus 0.8651421397012851
P82251 SLC7A9 b(0,+)-type amino acid transporter 1 Tier 1 0.805 1 A_surface 4 85.44 1 0     0 0   0 cystinuria 0.8484952668941285
Q695T7 SLC6A19 Sodium-dependent neutral amino acid transporter B(0)AT1 Tier 1 0.804 1 A_surface 19 90.0 1 0     0 0   0 Hartnup disease 0.8464240093600148
P41180 CASR Extracellular calcium-sensing receptor Tier 1 0.804 1 A_surface 31 75.69 1 0     0 0   0 familial hypocalciuric hypercalcemia 1 0.8460848589627423
Q05586 GRIN1 Glutamate receptor ionotropic, NMDA 1 Tier 1 0.803 1 A_surface 84 82.88 1 0     0 0   0 neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant 0.8446685494288694
O43526 KCNQ2 Potassium voltage-gated channel subfamily KQT member 2 Tier 1 0.803 1 A_surface 24 58.19 1 0     0 0   0 Benign familial neonatal seizures 0.8423358217314708
Q9HBA0 TRPV4 Transient receptor potential cation channel subfamily V member 4 Tier 1 0.801 1 A_surface 19 71.62 1 0     0 0   0 metatropic dysplasia 0.8356240344517467
Q8IZF0 NALCN Sodium leak channel NALCN Tier 1 0.796 1 A_surface 5 76.69 1 0     0 0   0 congenital contractures of the limbs and face, hypotonia, and developmental delay 0.8198033442161259
P41181 AQP2 Aquaporin-2 Tier 1 0.795 1 A_surface 7 91.75 1 0     0 0   0 diabetes insipidus, nephrogenic, autosomal 0.817870726313342
Q9H222 ABCG5 ATP-binding cassette sub-family G member 5 Tier 1 0.793 1 A_surface 8 85.06 1 0     0 0   0 sitosterolemia 0.810555184820483
Q12866 MERTK Tyrosine-protein kinase Mer Tier 1 0.79 1 A_surface 42 72.25 0 0     0 0   0 retinitis pigmentosa 0.7985580877708576
Q9H1D0 TRPV6 Transient receptor potential cation channel subfamily V member 6 Tier 1 0.789 1 A_surface 24 80.56 1 0     0 0   0 hyperparathyroidism, transient neonatal 0.7964821997780153
P16871 IL7R Interleukin-7 receptor subunit alpha Tier 1 0.789 1 A_surface 8 67.44 0 0     0 0   0 immunodeficiency 104 0.7983119488718231
P15509 CSF2RA Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Tier 1 0.788 1 A_surface 2 82.0 0 0     0 0   0 Congenital pulmonary alveolar proteinosis 0.7922592394513138
Q14028 CNGB1 Cyclic nucleotide-gated channel beta-1 Tier 1 0.788 1 A_surface 11 57.66 1 0     0 0   0 retinitis pigmentosa 0.7931901344765326
P24530 EDNRB Endothelin receptor type B Tier 1 0.786 1 A_surface 17 75.0 1 0     0 0   0 Waardenburg syndrome type 4A 0.7874601728728147
Q03431 PTH1R Parathyroid hormone/parathyroid hormone-related peptide receptor Tier 1 0.786 1 A_surface 52 70.94 1 0     0 0   0 metaphyseal chondrodysplasia, Jansen type 0.7859378587442476
O60741 HCN1 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 Tier 1 0.786 1 A_surface 12 68.94 1 0     0 0   0 Generalized epilepsy with febrile seizures-plus 0.7853938745545654
O43909 EXTL3 Exostosin-like 3 Tier 1 0.785 1 A_surface 4 83.69 1 0     0 0   0 immunoskeletal dysplasia with neurodevelopmental abnormalities 0.7837827977649315
P22888 LHCGR Lutropin-choriogonadotropic hormone receptor Tier 1 0.785 1 A_surface 4 80.12 1 0     0 0   0 Leydig cell hypoplasia, type 1 0.783461117057047
P23416 GLRA2 Glycine receptor subunit alpha-2 Tier 1 0.784 1 A_surface 13 83.81 1 0     0 0   0 intellectual developmental disorder, X-linked, syndromic, Pilorge type 0.7805605973560554
P56696 KCNQ4 Potassium voltage-gated channel subfamily KQT member 4 Tier 1 0.783 1 A_surface 13 65.25 1 0     0 0   0 autosomal dominant nonsyndromic hearing loss 2A 0.7765455627642878
Q13224 GRIN2B Glutamate receptor ionotropic, NMDA 2B Tier 1 0.783 1 A_surface 36 60.69 1 0     0 0   0 intellectual disability, autosomal dominant 6 0.7771650025965382
P30531 SLC6A1 Sodium- and chloride-dependent GABA transporter 1 Tier 1 0.782 1 A_surface 5 87.94 1 0     0 0   0 epilepsy with myoclonic atonic seizures 0.7729414443362785
Q9H251 CDH23 Cadherin-23 Tier 1 0.781 1 A_surface 6 76.75 0 0     0 0   0 Usher syndrome type 1 0.7713456285400272
Q9NY46 SCN3A Sodium channel protein type 3 subunit alpha Tier 1 0.781 1 A_surface 2 68.25 1 0     0 0   0 familial focal epilepsy with variable foci 0.7708874082891223
Q07699 SCN1B Sodium channel regulatory subunit beta-1 Tier 1 0.779 1 A_surface 36 87.06 1 0     0 0   0 Generalized epilepsy with febrile seizures-plus 0.7638796221342504
P21579 SYT1 Synaptotagmin-1 Tier 1 0.779 1 A_surface 24 81.81 0 0     0 0   0 infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome 0.7640586502824556
Q01668 CACNA1D Voltage-dependent L-type calcium channel subunit alpha-1D Tier 1 0.777 1 A_surface 6 64.31 1 0     0 0   0 aldosterone-producing adenoma with seizures and neurological abnormalities 0.7565859403082721
P30518 AVPR2 Vasopressin V2 receptor Tier 1 0.776 1 A_surface 38 76.0 1 0     0 0   0 nephrogenic syndrome of inappropriate antidiuresis 0.7522383646690638
O15399 GRIN2D Glutamate receptor ionotropic, NMDA 2D Tier 1 0.776 1 A_surface 13 63.22 1 0     0 0   0 developmental and epileptic encephalopathy, 46 0.7529662497608808
P48167 GLRB Glycine receptor subunit beta Tier 1 0.775 1 A_surface 12 78.06 1 0     0 0   0 hyperekplexia 2 0.7488854563756028
P08588 ADRB1 Beta-1 adrenergic receptor Tier 1 0.775 1 A_surface 7 75.31 1 0     0 0   0 hypertension 0.7498467911536156
P14416 DRD2 D(2) dopamine receptor Tier 1 0.774 1 A_surface 11 72.44 1 0     0 0   0 major depressive disorder 0.7450892965426774
P40259 CD79B B-cell antigen receptor complex-associated protein beta chain Tier 1 0.773 1 A_surface 5 75.38 1 0     0 0   0 diffuse large B-cell lymphoma 0.7442791518522275
Q96E22 NUS1 Dehydrodolichyl diphosphate synthase complex subunit NUS1 Tier 1 0.769 1 A_surface 9 82.0 0 0     0 0   0 congenital disorder of glycosylation type I 0.7309837554022756
Q8NET8 TRPV3 Transient receptor potential cation channel subfamily V member 3 Tier 1 0.769 1 A_surface 34 76.5 1 0     0 0   0 Olmsted syndrome 1 0.7314859339994324
Q9NPC2 KCNK9 Potassium channel subfamily K member 9 Tier 1 0.769 1 A_surface 22 75.94 1 0     0 0   0 Birk-Barel syndrome 0.73064701208734
P28223 HTR2A 5-hydroxytryptamine receptor 2A Tier 1 0.761 1 A_surface 38 73.75 1 0     0 0   0 major depressive disorder 0.703395899986692
Q14973 SLC10A1 Hepatic sodium/bile acid cotransporter Tier 1 0.758 1 A_surface 11 83.5 1 0     0 0   0 hypercholanemia, familial, 2 0.6937781800382379
P48546 GIPR Gastric inhibitory polypeptide receptor Tier 1 0.758 1 A_surface 13 78.5 1 0     0 0   0 obesity 0.6926187130965883
P17787 CHRNB2 Neuronal acetylcholine receptor subunit beta-2 Tier 1 0.757 1 A_surface 15 80.25 1 0     0 0   0 autosomal dominant nocturnal frontal lobe epilepsy 0.6909638310095522
P35372 OPRM1 Mu-type opioid receptor Tier 1 0.756 1 A_surface 25 76.56 1 0     0 0   0 Pain 0.6879594792391589
O43570 CA12 Carbonic anhydrase 12 Tier 1 0.754 1 A_surface 40 87.81 0 0     0 0   0 isolated hyperchlorhidrosis 0.6794515382695604
Q02223 TNFRSF17 Tumor necrosis factor receptor superfamily member 17 Tier 1 0.753 1 A_surface 11 64.94 0 0     0 0   0 multiple myeloma 0.6779550435975632
Q9H2S1 KCNN2 Small conductance calcium-activated potassium channel protein 2 Tier 1 0.752 1 A_surface 15 76.5 1 0     0 0   0 neurodevelopmental disorder with or without variable movement or behavioral abnormalities 0.6734482320998599
P14784 IL2RB Interleukin-2 receptor subunit beta Tier 1 0.751 1 A_surface 8 64.62 1 0     0 0   0 Immunodeficiency syndrome with autoimmunity 0.6699659932233261
Q8NCM2 KCNH5 Voltage-gated delayed rectifier potassium channel KCNH5 Tier 1 0.75 1 A_surface 6 72.12 1 0     0 0   0 developmental and epileptic encephalopathy 112 0.6672418587623622
Q9NYG8 KCNK4 Potassium channel subfamily K member 4 Tier 1 0.749 1 A_surface 12 78.69 0 0     0 0   0 facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome 0.6619991022563834
P11229 CHRM1 Muscarinic acetylcholine receptor M1 Tier 1 0.749 1 A_surface 7 74.69 1 0     0 0   0 Parkinson disease 0.6645568245460437

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 1273.273ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target